AVADEL PHARMACEUTICALS PLC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Avadel Pharmaceuticals Plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2017 to Q2 2024.
  • Avadel Pharmaceuticals Plc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.15M, a 74.4% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.15M +$919K +74.4% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.37M +$899K +60.9% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.59M +$878K +51.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $2.8M +$857K +44% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.24M -$945K -43.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.48M -$935K -38.8% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.71M -$939K -35.4% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.95M -$123K -5.94% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $2.18M -$69K -3.07% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $2.41M -$17K -0.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.65M +$48K +1.84% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $2.07M -$796K -27.8% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $2.25M -$868K -27.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $2.43M -$938K -27.9% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $2.6M -$1.01M -27.9% Dec 31, 2020 10-K 2022-03-16
Q3 2020 $2.87M -$1.52M -34.6% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $3.12M -$2.34M -42.8% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.37M -$2.44M -42% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.61M +$3.61M Dec 31, 2019 10-K 2021-03-09
Q3 2019 $4.39M -$1.58M -26.4% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $5.45M +$578K +11.9% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $5.8M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 -$2.91M -100% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $5.96M Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $4.88M Jun 30, 2018 10-Q 2018-08-07
Q4 2017 $2.91M Dec 31, 2017 10-K 2019-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.